Prognostic and Clinical Significance of Aspartate Aminotransferase-to-Lymphocyte Ratio Index in Individuals with Liver Cancer: A Meta-Analysis

Overview

Journal Dis Markers

Publisher Wiley

Specialty Biochemistry

Date 2022 Feb 21

PMID 35186165

Authors

Xiulan Peng

Yali Huang

Min Zhang

Yan Chen

Lihua Zhang

Anbing He

Renfeng Luo

Affiliations

Soon will be listed here.

Abstract

Objective: This study was aimed at exploring the prognostic and clinicopathological roles of aspartate aminotransferase-to-lymphocyte ratio index (ALRI) in patients with hepatocellular carcinoma via a meta-analysis.

Methods: The PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang, and VIP databases were comprehensively searched from inception to November 20, 2021. Pooled hazard ratio (HR) and corresponding 95% confidence interval (CI) were used to evaluate the relationship between ALRI and overall survival (OS) as well as progression-free survival (PFS) in patients with hepatocellular carcinoma. Odds ratio (OR) and the corresponding 95% CI were also used to investigate correlations between clinical factors and ALRI in patients with hepatocellular carcinoma.

Results: A total of 3914 patients with hepatocellular carcinoma from eleven retrospective cohorts were included in this meta-analysis. The combined results revealed that patients with hepatocellular carcinoma with elevated ALRI tended to have unfavorable OS (HR 1.53 [95% CI 1.25-1.82]; < 0.001). Pooled HRs revealed that high ALRI was an independent risk factor for inferior PFS in patients with hepatocellular carcinoma (HR 1.36 [95% CI 1.10-1.63]; < 0.001). In addition, high ALRI was strongly associated with male sex (OR 1.32 [95% CI 1.02-1.70]; = 0.035), presence of cirrhosis (OR 1.68 [95% CI 1.01-2.81]; = 0.046), larger tumor size (OR 2.25 [95% CI 1.31-3.88]; < 0.001), presence of portal vein tumor thrombus (OR 2.50 [95% CI 1.52-4.11]; < 0.001), and distant metastasis (OR 1.72 [95% CI 1.05-2.82]; = 0.031).

Conclusion: Elevated ALRI in patients with hepatocellular carcinoma predicted inferior survival outcomes and was strongly associated with some important features of hepatocellular carcinoma.

Citing Articles

Is immunotherapy-related liver injury more common in patients with hepatocellular carcinoma than in other advanced solid tumors?.

Wang L, Wei Y, Zhang M Hepatobiliary Surg Nutr. 2025; 14(1):176-178.

PMID: 39925919 PMC: 11806158. DOI: 10.21037/hbsn-24-613.

Aminotransferase-to-lymphocyte ratio as a valuable prognostic marker for patients with stage I-III colorectal cancer: a retrospective study.

Xie H, Wei L, Tang S, Gan J Front Oncol. 2024; 14:1446557.

PMID: 39624626 PMC: 11609077. DOI: 10.3389/fonc.2024.1446557.

Diagnostic value of tissue plasminogen activator-inhibitor complex in sepsis-induced liver injury: A single-center retrospective case-control study.

Zhou Y, He L, Qi Y, Huang Y, Hu B, Liu J World J Hepatol. 2024; 16(11):1255-1264.

PMID: 39606162 PMC: 11586747. DOI: 10.4254/wjh.v16.i11.1255.

Immune cell dynamics and the impact on the efficiency of transvascular antitumor interventional therapies in hepatocellular carcinoma patients.

Sun Y, Zhang H, Li Y, Zhou C, Han J Front Immunol. 2024; 15:1450525.

PMID: 39439786 PMC: 11493604. DOI: 10.3389/fimmu.2024.1450525.

Prognostic significance of the aspartate aminotransferase to lymphocyte ratio index in patients with acute myocardial infarction.

Liu H, Zhao F, Yin J, Liu T, Liu B Immun Inflamm Dis. 2024; 12(6):e1306.

PMID: 38888385 PMC: 11184641. DOI: 10.1002/iid3.1306.

References

Ahn J, Won Jun D, Lee H, Moon J . Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses. Clin Nutr. 2018; 38(5):2023-2030. DOI: 10.1016/j.clnu.2018.09.022. View

Liao M, Sun J, Zhang Q, Tang C, Zhou Y, Cao M . A Novel Post-Operative ALRI Model Accurately Predicts Clinical Outcomes of Resected Hepatocellular Carcinoma Patients. Front Oncol. 2021; 11:665497. PMC: 8290124. DOI: 10.3389/fonc.2021.665497. View

Zhao L, Yang D, Ma X, Liu M, Wu D, Zhang X . The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments. J Cancer. 2019; 10(10):2299-2311. PMC: 6584423. DOI: 10.7150/jca.30663. View

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015; 350:g7647. DOI: 10.1136/bmj.g7647. View

Chew V, Chen J, Lee D, Loh E, Lee J, Lim K . Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut. 2011; 61(3):427-38. PMC: 3273680. DOI: 10.1136/gutjnl-2011-300509. View

Kahraman D, Kahraman T, Cetin-Atalay R . Targeting PI3K/Akt/mTOR Pathway Identifies Differential Expression and Functional Role of IL8 in Liver Cancer Stem Cell Enrichment. Mol Cancer Ther. 2019; 18(11):2146-2157. DOI: 10.1158/1535-7163.MCT-19-0004. View

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

Wu W, Wang Q, Han D, Li J, Nie Y, Guo D . Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection. Cancer Cell Int. 2021; 21(1):500. PMC: 8447627. DOI: 10.1186/s12935-021-02204-3. View

Witjes C, IJzermans J, van der Eijk A, Hansen B, Verhoef C, de Man R . Quantitative HBV DNA and AST are strong predictors for survival after HCC detection in chronic HBV patients. Neth J Med. 2012; 69(11):508-13. View

10.

Wang D, Hu X, Xiao L, Long G, Yao L, Wang Z . Prognostic Nutritional Index and Systemic Immune-Inflammation Index Predict the Prognosis of Patients with HCC. J Gastrointest Surg. 2020; 25(2):421-427. PMC: 7904713. DOI: 10.1007/s11605-019-04492-7. View

11.

El-Serag H, Rudolph K . Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132(7):2557-76. DOI: 10.1053/j.gastro.2007.04.061. View

12.

Zheng C, Zheng L, Yoo J, Guo H, Zhang Y, Guo X . Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell. 2017; 169(7):1342-1356.e16. DOI: 10.1016/j.cell.2017.05.035. View

13.

He C, Peng W, Li C, Wen T . Postoperative aspartate aminotransferase to lymphocyte ratio index change is an independent predictor of survival in patients with small hepatocellular carcinoma. Medicine (Baltimore). 2017; 96(45):e8540. PMC: 5690755. DOI: 10.1097/MD.0000000000008540. View

14.

Cong R, Kong F, Ma J, Li Q, Wu Q, Ma X . Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer. BMC Cancer. 2020; 20(1):464. PMC: 7245911. DOI: 10.1186/s12885-020-06953-8. View

15.

Guo Z, Chen W, Dai G, Huang Y . Cordycepin suppresses the migration and invasion of human liver cancer cells by downregulating the expression of CXCR4. Int J Mol Med. 2019; 45(1):141-150. PMC: 6889938. DOI: 10.3892/ijmm.2019.4391. View

16.

Zhang Y, Xiao G, Wang R . Clinical significance of systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) in patients with esophageal cancer: a meta-analysis. Cancer Manag Res. 2019; 11:4185-4200. PMC: 6515544. DOI: 10.2147/CMAR.S190006. View

17.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

18.

Yang Z, Zhang J, Lu Y, Xu Q, Tang B, Wang Q . Aspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization. Oncotarget. 2015; 6(40):43090-8. PMC: 4767493. DOI: 10.18632/oncotarget.5719. View

19.

Gao J, Wang Y, Li F, Zhu Z, Han B, Wang R . Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Are Respectively Associated with Prognosis of Gastric Cancer with Liver Metatasis Undergoing and without Hepatectomy. Biomed Res Int. 2019; 2019:4213623. PMC: 6800959. DOI: 10.1155/2019/4213623. View

20.

Chan S, Wong L, Chan K, Chow C, Tong J, Yip T . Development of a Novel Inflammation-Based Index for Hepatocellular Carcinoma. Liver Cancer. 2020; 9(2):167-181. PMC: 7206612. DOI: 10.1159/000504252. View